CIK 0000875045 · Large accelerated filer
BIOGEN INC.
Sign in to watch- Ticker
- BIIB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330112644
- Phone
- 6176792000
- Business address
- 225 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
- 8-K Event Bylaws or fiscal year change · Shareholder vote results
- S-8 Other Securities Offered to Employees in Benefit Plans
- 4 Shares withheld for taxes Head of Corporate Development gave up 276 shares (to pay taxes)
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- PRE 14A Proxy Proxy Statement (Preliminary)
- 4 Planned sale Head of Development sold 93 shares at $213.09 ($19,817)
- 4 Shares withheld for taxes Head of Pharm Ops and Tech gave up 117 shares (to pay taxes)
- 144 Insider Sale of Securities
- 4 Planned sale Head of Development sold 262 shares at $221.23 ($57,962)
- 144 Insider Sale of Securities
- 4 Shares withheld for taxes EVP Chief Legal Officer gave up 2,437 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Human Resources gave up 2,264 shares (to pay taxes)
- 4 Shares withheld for taxes Head of Global Product Strat. gave up 952 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Accounting Officer gave up 396 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Chief Financial Officer gave up 3,438 shares (to pay taxes)
- 4 Shares withheld for taxes Head of Pharm Ops and Tech gave up 610 shares (to pay taxes)
Page 10 of 137 · 2,721 filings